TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10975783

Group type: EXPERIMENTAL
Intervention: Two-week dual therapy (lansoprazole 30 mg plus amoxycillin 1 g bid for two weeks)
Number of subjects: 165

Group type: COMPARATOR
Intervention: One-week triple therapy (lansoprazole 30 mg plus amoxycillin 1 g plus tinidazole 500 mg bid for one week plus lansoprazole qd for an additional week)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori cured patients
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori not cured patients
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Triple therapy (after one year follow-up)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Dual therapy (after one year follow-up)
Number of subjects: 165
Study: 9006835

Group type: EXPERIMENTAL
Intervention: GnRH analogue goserelin followed by laparoscopic surgery
Number of subjects: 19

Group type: COMPARATOR
Intervention: GnRH analogue goserelin
Number of subjects: 19
Study: 1592541

Group type: EXPERIMENTAL
Intervention: 350 mg oral sustained release theophylline twice a day
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 4068672

Group type: EXPERIMENTAL
Intervention: PO2 Aerobic Exerciser
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no PO2 Aerobic Exerciser)
Number of subjects: 17
Study: 30401001

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 16867
Study: 27329968

Group type: EXPERIMENTAL
Intervention: 150 IU recombinant human FSH s.c. every other day for 12 weeks
Number of subjects: 89
Study: 22445423

Group type: EXPERIMENTAL
Intervention: Active model group (n=176) with self-evaluation kit and treatment of metronidazole 500 mg twice daily for 7 days
Number of subjects: 331

Group type: COMPARATOR
Intervention: Control group (n=155)
Number of subjects: 331
Study: 22053609

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral block
Number of subjects: 40
Study: 18207667

Group type: EXPERIMENTAL
Intervention: Surgery and preoperative or postoperative radiotherapy or chemoradiation
Number of subjects: 554
Study: 15805436

Group type: EXPERIMENTAL
Intervention: FBAT communities
Number of subjects: 5
Study: 14623548

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (exemestane, anastrozole)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination strategies of gonadotrophin agonists and aromatase inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low doses of aromatase inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aromatase inhibitors
Number of subjects: 0
Study: 10714753

Group type: EXPERIMENTAL
Intervention: GH therapy (somatotropin, 0.222 mg/kg/week, divided into 3 doses each week)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GH therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 8928847

Group type: EXPERIMENTAL
Intervention: L-NMMA (3 mg/kg in 10 ml saline)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (10 ml saline)
Number of subjects: 23
Study: 1626990

Group type: EXPERIMENTAL
Intervention: Tartrazine 50 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Glucose placebo
Number of subjects: 12
Study: 4058956

Group type: EXPERIMENTAL
Intervention: i.v. naloxone (0.04 mg/kg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 13
Study: 31677621

Group type: EXPERIMENTAL
Intervention: Posterior lumbar interbody fusion (PLIF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Posterolateral fusion (PLF)
Number of subjects: 40
Study: 30241688

Group type: EXPERIMENTAL
Intervention: SL edaravone 30 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: IV edaravone 30 mg infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both SL and IV administration
Number of subjects: 10
Study: 27175799

Group type: EXPERIMENTAL
Intervention: Web-based training in communication skills and use of a patient booklet
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: Communication skills and patient booklet
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: Communication groups with a booklet
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) point-of-care test
Number of subjects: 2886
Study: 25236883

Group type: EXPERIMENTAL
Intervention: Standard care plus multidisciplinary group clinics
Number of subjects: 198

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 198
Study: 22989231

Group type: EXPERIMENTAL
Intervention: UP4FUN intervention
Number of subjects: 372

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 372
Study: 20864664

Group type: EXPERIMENTAL
Intervention: Patient and general practitioner systematic follow-up intervention
Number of subjects: 523
Study: 19128346

Group type: EXPERIMENTAL
Intervention: Nonpharmacological management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tailored treatment plans
Number of subjects: 0
Study: 18681992

Group type: EXPERIMENTAL
Intervention: HP‐HMG
Number of subjects: 986

Group type: COMPARATOR
Intervention: rFSH
Number of subjects: 986
Study: 15164501

Group type: EXPERIMENTAL
Intervention: Long-term morphine-clopheline epidural analgesia
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional analgesia (intravenous injection of morphine)
Number of subjects: 76
Study: 11308435

Group type: EXPERIMENTAL
Intervention: Revised CONSORT statement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 8989246

Group type: EXPERIMENTAL
Intervention: 0.6 IU/day for 12 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.6 IU for 4 weeks followed by 1.2 IU/day for 8 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.6 IU for 4 weeks, followed by 1.2 IU/day for 4 weeks and 1.8 IU/day thereafter
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GH therapy at doses of 0.6 and 1.2 IU/day
Number of subjects: 60
Study: 8285749

Group type: EXPERIMENTAL
Intervention: Non-selective paralysis (pancuronium during mechanical ventilation)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Selective paralysis (synchronised ventilation with pancuronium if consistently expiring during inspiratory phase)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Selective paralysis (synchronised ventilation)
Number of subjects: 193
Study: 2955253

Group type: EXPERIMENTAL
Intervention: Low MW heparin (Kabi 2165) administered as 5000 or 10,000 anti-factor Xa units, s.c., half an hour prior to dialysis
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Single bolus injection of 5000 anti-factor Xa units of low MW heparin given i.v.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Infusion of low MW heparin at 5000 anti-factor Xa units bolus plus 1500 anti-factor Xa units/h
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Infusion of low MW heparin at approximately 4000 anti-factor Xa units bolus plus 750 anti-factor Xa units/h
Number of subjects: 16
Study: 12521812

Group type: EXPERIMENTAL
Intervention: Non-closure of the visceral and parietal peritoneum (study open group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Closure of the visceral and parietal peritoneum (control closed group)
Number of subjects: 66
Study: 31760401

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 240
Study: 29901496

Group type: EXPERIMENTAL
Intervention: Active low-frequency repetitive transcranial magnetic stimulation (rTMS) over bilateral presupplementary motor area (pre-SMA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham low-frequency repetitive transcranial magnetic stimulation (rTMS) over bilateral presupplementary motor area (pre-SMA)
Number of subjects: 40
Study: 26703923

Group type: EXPERIMENTAL
Intervention: Self-management programme (SPACE for COPD) consisting of an education manual and consultation
Number of subjects: 184

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 184
Study: 25013996

Group type: EXPERIMENTAL
Intervention: Low-dose GH (LGH) therapy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 22699446

Group type: EXPERIMENTAL
Intervention: Purified chick embryo cell (PCECV) rabies vaccine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Purified verocell rabies vaccine (PVRV)
Number of subjects: 80
Study: 20015921

Group type: EXPERIMENTAL
Intervention: Sublingual fentanyl 400 microg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sublingual fentanyl 100 and 200 microg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 18809612

Group type: EXPERIMENTAL
Intervention: Hypnosis intervention (five weekly sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 60
Study: 15757817

Group type: EXPERIMENTAL
Intervention: Paromomycin sulfate ointment (15% in urea) applied twice daily for 20 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Meglumine antimonate (1 ml intradermally every other day for 20 days)
Number of subjects: 60
Study: 11828262

Group type: EXPERIMENTAL
Intervention: Vitamin E (dl‐alpha‐tocopherol) 1000 mg/day for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10049268

Group type: EXPERIMENTAL
Intervention: Fasting conditions (twice)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Antacids (aluminum-magnesium)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High-fat meal
Number of subjects: 14
Study: 7589655

Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRH-a) initiated in early follicular phase
Number of subjects: 5

Group type: COMPARATOR
Intervention: GnRH agonist (GnRH-a) initiated in midluteal phase
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRH-a) initiated in late luteal phase
Number of subjects: 5
Study: 2176098

Group type: EXPERIMENTAL
Intervention: CP buffered with sodium bicarbonate (pH 7.7)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CP buffered with tromethamine (pH 7.7)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Commercial CP (pH 4.35)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CP buffered with sodium bicarbonate and tromethamine (pH 7.7)
Number of subjects: 40
Study: 88358

Group type: EXPERIMENTAL
Intervention: Large VEP amplitude with large ERD
Number of subjects: 10

Group type: COMPARATOR
Intervention: Small VEP amplitude with small ERD
Number of subjects: 10
Study: 31701170

Group type: EXPERIMENTAL
Intervention: TPEx regimen (docetaxel, cisplatin, and cetuximab)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pembrolizumab, 5‑FU, and cis-/carboplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pembrolizumab monotherapy (for selected patients with PD-L1 CPS ≥1 and ≥20)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extreme regimen (cisplatin, 5‑fluorouracil [5‐FU], cetuximab)
Number of subjects: 0
Study: 30580857

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 100
Study: 27146582

Group type: EXPERIMENTAL
Intervention: Endometrial biopsy using a Pipelle catheter combined with intrauterine insemination
Number of subjects: 360

Group type: COMPARATOR
Intervention: Intrauterine insemination without endometrial biopsy
Number of subjects: 360
Study: 24682081

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89

Group type: COMPARATOR
Intervention: Naloxone
Number of subjects: 89
Study: 21984060

Group type: EXPERIMENTAL
Intervention: One stage-modified transmastoid approach for surgical repair
Number of subjects: 33
Study: 20665349

Group type: EXPERIMENTAL
Intervention: Younger cane users
Number of subjects: 32

Group type: COMPARATOR
Intervention: Older cane users
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Younger participants
Number of subjects: 32

Group type: COMPARATOR
Intervention: Older participants
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Early-onset visual impairment
Number of subjects: 32

Group type: COMPARATOR
Intervention: Later-onset visual impairment
Number of subjects: 32
Study: 17868011

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment over a 6-week course
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prophylactic drug treatment over a 6-month period
Number of subjects: 0
Study: 15892268

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conventional treatments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 14719294

Group type: EXPERIMENTAL
Intervention: Huo Nao Fang
Number of subjects: 120

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 120
Study: 10808977

Group type: EXPERIMENTAL
Intervention: Tailored telephone counseling
Number of subjects: 1099

Group type: EXPERIMENTAL
Intervention: Tailored print communications
Number of subjects: 1099

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1099
Study: 8972953

Group type: EXPERIMENTAL
Intervention: Topical anaesthetic EMLA cream
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Electronic nerve stimulation
Number of subjects: 100
Study: 1479198

Group type: EXPERIMENTAL
Intervention: Combined hyperthermia (HT) and radiation therapy (XRT)
Number of subjects: 0
Study: 6428504

Group type: EXPERIMENTAL
Intervention: Inhalation of 35% carbon dioxide and 65% oxygen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhalation of 35% carbon dioxide and 65% oxygen preceded by 60 mg propranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (air)
Number of subjects: 0
Study: 30839256

Group type: EXPERIMENTAL
Intervention: InMotion 3.0 (IMT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bi-Manu-Track (BMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Treatment (CT)
Number of subjects: 30
Study: 29225020

Group type: EXPERIMENTAL
Intervention: Arthroscopic Wafer Procedure (AWP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ulnar Shortening Osteotomy (USO)
Number of subjects: 42
Study: 27611236

Group type: EXPERIMENTAL
Intervention: Access to an iPad containing additional information about breast cancer (13 women)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group without access to the iPad information (26 women)
Number of subjects: 39
Study: 24660799

Group type: EXPERIMENTAL
Intervention: Martial artists (black belt)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Sportive individuals (without explicit balance components)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Nonsportive controls
Number of subjects: 143
Study: 22759936

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure Therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relaxation Therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy
Number of subjects: 0
Study: 20491718

Group type: EXPERIMENTAL
Intervention: Iterative hypothesis testing (IHT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Problem-based learning
Number of subjects: 72
Study: 18588702

Group type: EXPERIMENTAL
Intervention: FairMed
Number of subjects: 60

Group type: COMPARATOR
Intervention: TENS
Number of subjects: 60
Study: 15978969

Group type: EXPERIMENTAL
Intervention: HRT with Presomen (1.25mg equine conjugated estrogens for 21 days + 5mg medrogeston for 11 days)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 11821275

Group type: EXPERIMENTAL
Intervention: Group 2 (15 +/- 1.5 mm)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Group 3 (20 +/- 1.5 mm)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Group 1 (10 +/- 1.5 mm)
Number of subjects: 180
Study: 9540025

Group type: EXPERIMENTAL
Intervention: Miglitol (50 or 100 mg t.i.d.)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Miglitol
Number of subjects: 345

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 345
Study: 8294388

Group type: EXPERIMENTAL
Intervention: Combined SSRI (sertraline or fluvoxamine) with moclobemide
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Moclobemide (150 to 800 mg/day) with sertraline (25 to 200 mg/day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Moclobemide (150 to 800 mg/day) with fluvoxamine (50 to 200 mg/day)
Number of subjects: 11
Study: 2660873

Group type: EXPERIMENTAL
Intervention: Sultamicillin (375 mg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Trimethoprim/sulfamethoxazole (160 mg/800 mg)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Sultamicillin
Number of subjects: 38

Group type: COMPARATOR
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 38
Study: 4261553

Group type: EXPERIMENTAL
Intervention: Spectinomycin 2 g
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Spectinomycin 4 g
Number of subjects: 667

Group type: COMPARATOR
Intervention: Procaine penicillin 2.4 million units (males)
Number of subjects: 667

Group type: COMPARATOR
Intervention: Procaine penicillin 4.8 million units (females)
Number of subjects: 667

Group type: COMPARATOR
Intervention: Procaine penicillin 2.4 million units (females)
Number of subjects: 667
Study: 31091748

Group type: EXPERIMENTAL
Intervention: Behavioral intervention with partial meal replacement
Number of subjects: 211
Study: 29283688

Group type: EXPERIMENTAL
Intervention: Protein extracts from medium of Adipose-derived stem cells (ADSCs) via microneedles
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ultrapure water
Number of subjects: 30
Study: 27687405

Group type: EXPERIMENTAL
Intervention: High pillow (HP) group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low pillow (LP) group
Number of subjects: 50
Study: 24885005

Group type: EXPERIMENTAL
Intervention: Video-based feedback of public oral presentations
Number of subjects: 142

Group type: COMPARATOR
Intervention: Classical oral presentations without feedback (Control)
Number of subjects: 142
Study: 22500387

Group type: EXPERIMENTAL
Intervention: Fuzheng Yiliu Recipe (FYR) combined with microwave ablation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Microwave ablation
Number of subjects: 60
Study: 20187877

Group type: EXPERIMENTAL
Intervention: Psychosocial stimulation for 2 years
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (LBW-T)
Number of subjects: 109
Study: 17962424

Group type: EXPERIMENTAL
Intervention: Carvedilol controlled-release 40 mg with ethanol (approximately 38 g)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Carvedilol controlled-release alone
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Carvedilol controlled-release with ethanol 2 hours after administration
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Carvedilol controlled-release alone or with ethanol
Number of subjects: 39
Study: 16236169

Group type: EXPERIMENTAL
Intervention: Steroid-naïve atopic asthmatic children
Number of subjects: 82

Group type: COMPARATOR
Intervention: Atopic nonasthmatic children
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Atopic asthmatic children receiving inhaled corticosteroids
Number of subjects: 82

Group type: COMPARATOR
Intervention: Healthy children
Number of subjects: 82
Study: 12404872

Group type: EXPERIMENTAL
Intervention: 10 ml of antivenom
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: 2 to 5 ml of antivenom
Number of subjects: 275

Group type: COMPARATOR
Intervention: No antivenom administration
Number of subjects: 275
Study: 9464716

Group type: EXPERIMENTAL
Intervention: Total laparoscopic hysterectomy (TLH)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Total abdominal hysterectomy (TAH)
Number of subjects: 143
Study: 8563848

Group type: EXPERIMENTAL
Intervention: Sinusoidal vibration (125 Hz, 87.5 m.s‐2 rms) for 30 minutes on the right hand
Number of subjects: 8

Group type: COMPARATOR
Intervention: Static load (10 N) without vibration
Number of subjects: 8
Study: 2697725

Group type: EXPERIMENTAL
Intervention: 1% fusidic acid viscous eye drops, instilled twice daily for 7 days
Number of subjects: 163

Group type: COMPARATOR
Intervention: rifamycin eye drops, four times daily for 7 days
Number of subjects: 163
Study: 12484

Group type: EXPERIMENTAL
Intervention: Oxypertine (10 mg every 12 hours, 20 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oxypertine after placebo (group III)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo after oxypertine (group III)
Number of subjects: 30
Study: 7104467

Group type: EXPERIMENTAL
Intervention: Conventional 4 mg tablet administered every 6 hours
Number of subjects: 15

Group type: COMPARATOR
Intervention: Controlled release 8 mg barrier coated-bead capsule administered every 12 hours
Number of subjects: 15

Group type: COMPARATOR
Intervention: Controlled release 8 mg repeat action tablet administered every 12 hours
Number of subjects: 15
Study: 31269007

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 44
Study: 29103414

Group type: EXPERIMENTAL
Intervention: Music listening (up to 60 min) with routine care
Number of subjects: 35

Group type: COMPARATOR
Intervention: Routine care with no music
Number of subjects: 35
Study: 25853935

Group type: EXPERIMENTAL
Intervention: Combination therapy (levosimendan + nesiritide)
Number of subjects: 120
Study: 24415446

Group type: EXPERIMENTAL
Intervention: Dietary intervention (NORDIET) for 6 weeks
Number of subjects: 1979

Group type: EXPERIMENTAL
Intervention: 5-year follow-up
Number of subjects: 1979

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1979
Study: 23200590

Group type: EXPERIMENTAL
Intervention: Domiciliary non-invasive ventilation in addition to long-term oxygen therapy (LTOT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Long-term oxygen therapy (LTOT)
Number of subjects: 100
Study: 18384995

Group type: EXPERIMENTAL
Intervention: iomeprol 400
Number of subjects: 80

Group type: COMPARATOR
Intervention: iodixanol 320
Number of subjects: 80
Study: 17514706

Group type: EXPERIMENTAL
Intervention: Therapeutic play
Number of subjects: 203

Group type: COMPARATOR
Intervention: Routine information preparation (Control)
Number of subjects: 203
Study: 15342839

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment, 33 microg/kg/day for 3 years
Number of subjects: 87

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 87